![Amanda Ferrier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Amanda Ferrier is currently the Chief Operating Officer at LumaBridge LLC since 2023.
She completed her undergraduate degree from Texas A&M University and the University of Texas Health Science Center At San Antonio.
Aktive Positionen von Amanda Ferrier
Unternehmen | Position | Beginn |
---|---|---|
LumaBridge LLC
![]() LumaBridge LLC BiotechnologyHealth Technology LumaBridge LLC is an oncology clinical research organization that offers comprehensive clinical research organization services, customized trials, and pioneering experience in immuno-oncology. The company is based in San Antonio, TX. The company's mission is to bring life-changing therapies to patients cost-effectively. LumaBridge has a huge network of research sites and offers innovative trial solutions and partnerships. LumaBridge was founded in 2014 by George E. Peoples and Daniel L. Hargrove, and the CEO is J. David Boyle. | Geschäftsführer | 09.08.2023 |
Ausbildung von Amanda Ferrier
Texas A&M University | Undergraduate Degree |
University of Texas Health Science Center At San Antonio | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
LumaBridge LLC
![]() LumaBridge LLC BiotechnologyHealth Technology LumaBridge LLC is an oncology clinical research organization that offers comprehensive clinical research organization services, customized trials, and pioneering experience in immuno-oncology. The company is based in San Antonio, TX. The company's mission is to bring life-changing therapies to patients cost-effectively. LumaBridge has a huge network of research sites and offers innovative trial solutions and partnerships. LumaBridge was founded in 2014 by George E. Peoples and Daniel L. Hargrove, and the CEO is J. David Boyle. | Health Technology |